GO
Loading...

Novartis AG

More

  • Market Insider: Earnings Loom in the Week Ahead Friday, 10 Jul 2009 | 8:17 PM ET
    NYSE Traders

    Earnings season should provide a fresh view of the U.S. economy and may shake the stock market out of its summer doldrums.

  • Software Giants Rush to Cash In on Carbon Counting Thursday, 9 Jul 2009 | 5:05 PM ET
    Smoke stacks in Heilongjiang province, China

    As the Markey-Waxman bill on carbon emissions cap-and-trade makes it way through the Senate, a new carbon-counting reality may soon be here for American businesses.

  • Homeland Security Braces for Possible H1N1 Outbreak Thursday, 9 Jul 2009 | 12:04 PM ET

    As flu season goes into high gear in the southern hemisphere, the U.S. Dept. of Homeland Security is preparing for a potential flu outbreak in the United States, according to its top official.

  • The Amgen D-mab D-bate Wednesday, 8 Jul 2009 | 11:25 AM ET
    Amgen

    Analysts are busy jawboning this morning about the side effect Amgen revealed cropped up in a large, late-stage study of its bone drug known as D-mab for breast cancer patients whose disease has spread to the bones.

  • Amgen Surges After Hours Tuesday, 7 Jul 2009 | 6:18 PM ET

    After hours shares of Amgen popped as much as 12%. What drove the stock that much higher?

  • Stocks Kick Off Quarter With Rally Wednesday, 1 Jul 2009 | 5:42 PM ET

    Both the S&P and Dow rose on Wednesday, the start of the third quarter, as reassuring manufacturing data reinforced hopes that the world's economy is on the road to recovery.

  • Crucell's Lovely RITA Wednesday, 24 Jun 2009 | 2:11 PM ET
    Rabies in the Americas 2009

    ACC, ADA, AHA, ASCO, ICAD, TCT. That's just a handful of the acronyms and abbreviations for scientific and medical conferences that I've attended over the years. But this year I might be able to add RITA to my dance card. I'd never heard of her (it) before this morning when I got this press release from Crucell, which owns technology for faster, better, cheaper vaccine manufacturing.

  • Pops & Drops: Alcoa, Evergreen Solar... Friday, 12 Jun 2009 | 6:00 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Alcoa and Evergreen Solar popped while Apple and Morgan Stanley dropped.

  • GSK & Pharma's Foray Into The Blogosphere Friday, 22 May 2009 | 10:39 AM ET
    GlaxoSmithKline

    I've got new competition. Sort of. GlaxoSmithKline sent me an email this morning calling my attention to its new external blog, "American Health: More Than Medicine." A pretty long name for a blog, one that screams that it went through the corporate approval wringer, but at least GSK is putting itself out there.

  • Worst Of Flu May Not Be Over: WHO Official Friday, 15 May 2009 | 11:01 AM ET
    Riders on the subway in Mexico City

    The World Health Organisation warned on Friday against a false sense of security from waning and apparently mild outbreaks of H1N1 flu, saying the worst may not be over.

  • The Novartis Apprentice: You're Hired! Wednesday, 13 May 2009 | 11:16 AM ET
    Novartis Headquarters

    What does it say when a drugmaker hires a Goldman Sachs investment banker as its next Chief Financial Officer? That's the question I'm asking after Novartis announced that it's tapped a managing director of investment banking at Goldman Sachs, Jonathan Symonds, as its CFO apprentice.

  • Cramer makes the call on viewers' favorite stocks.

  • Pros Say: Banks 'Know What They're Doing' (UPDATED) Thursday, 7 May 2009 | 5:38 PM ET

    Stocks turned lower on Thursday as bank stocks backed off their early rally. Fed Reserve Chairman Bernanke said increasing the effectiveness of bank supervision is a "top priority" for the Fed. Treasury Secretary Tim Geithner sought to ease fears about the results by saying that none of the banks being tested face the risk of insolvency. (UPDATED: Stress test results released.)

  • Vanda Snaps Victory From The Jaws Of Defeat Thursday, 7 May 2009 | 3:50 PM ET

    Out of nowhere late yesterday the FDA approved VNDA's schizophrenia drug with the funky name Fanapt.

  • Pros Say: Banks 'Already Know What They're Doing' Thursday, 7 May 2009 | 1:34 PM ET

    Stocks turned lower on Thursday as bank stocks backed off their early rally. Fed Reserve Chairman Bernanke said increasing the effectiveness of bank supervision is a "top priority" for the Fed. Treasury Secretary Tim Geithner sought to ease fears about the results by saying that none of the banks being tested face the risk of insolvency.

  • Stock Picks: 6 Health Care—Stimulus Plays Wednesday, 29 Apr 2009 | 5:27 PM ET

    Investors can benefit from certain health care companies that will be boosted by the stimulus package, said Les Funtleyder, health care strategist of Miller Tabak.

  • Trading Swine Flu: Winners and Losers Tuesday, 28 Apr 2009 | 9:26 AM ET

    The futures are down again this morning with uncertainty of the impact that the swine flu will ultimately have.  So far, nearly 150 people have died in Mexico from the disease as it continues to spread around the world.  Here are some of the stocks that moved most as the story has developed.

  • Pharma Stocks Get a 'Swine Flu Rally' (Video) Monday, 27 Apr 2009 | 12:53 PM ET

    Swine Flu: global pandemic or paranoia? President Obama said the health emergency declaration was merely a prudent measure. But many pharmaceutical stocks were sharply higher Monday in reaction to flu outbreaks — and the gains seemed to ripple through the sector.

  • Cubist Pharmaceuticals is up more than 12 percent today with heavy options activity amid rumors that the company will be bought by Swiss drug giant Novartis.

  • Novartis Drug Approved as Kidney Cancer Treatment Monday, 30 Mar 2009 | 6:09 PM ET

    A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs.